Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
14 2월 2024 - 7:17AM
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal
solutions company, will announce its financial results for the
fourth quarter and full year ended December 31, 2023 after the
market close on Tuesday, February 20, 2024. A copy of the release
will be available on the Globus Medical website at
www.investors.globusmedical.com.
Following the announcement, Globus Medical will
hold a teleconference to discuss its performance with the
investment community at 4:30 p.m. Eastern Time. Participants may
access the conference call live via webcast on the Investors page
of Globus Medical’s website at
https://www.investors.globusmedical.com/news-events/events-webcasts.
To participate via telephone, please register in
advance at this link. Upon registration, all telephone participants
will receive a confirmation email detailing how to join the
conference call, including the dial-in number along with a unique
passcode and registrant ID that can be used to access the call.
The audio archive will be available after the call
on the Investor page of the Globus Medical website.
About Globus Medical, Inc.
Globus Medical, Inc. is a leading
musculoskeletal solutions company based in Audubon, PA. The company
was founded in 2003 by an experienced team of professionals with a
shared vision to create products that enable surgeons to promote
healing in patients with musculoskeletal disorders. Additional
information can be accessed at www.globusmedical.com.
Safe Harbor Statements
All statements included in this press release
other than statements of historical fact are forward-looking
statements and may be identified by their use of words such as
“believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,”
“continue,” “anticipate,” “intend,” “expect,” “plan” and other
similar terms. These forward-looking statements are based on our
current assumptions, expectations and estimates of future events
and trends. Forward-looking statements are only predictions and are
subject to many risks, uncertainties and other factors that may
affect our businesses and operations and could cause actual results
to differ materially from those predicted. These risks and
uncertainties include, but are not limited to, the risks and costs
associated with the integration of, and our ability to integrate
the NuVasive business successfully and to achieve anticipated
synergies, health epidemics, pandemics and similar outbreaks,
including the COVID-19 pandemic, factors affecting our quarterly
results, our ability to manage our growth, our ability to sustain
our profitability, demand for our products, our ability to compete
successfully (including without limitation our ability to convince
surgeons to use our products and our ability to attract and retain
sales and other personnel), our ability to rapidly develop and
introduce new products, our ability to develop and execute on
successful business strategies, our ability to comply with laws and
regulations that are or may become applicable to our businesses,
our ability to safeguard our intellectual property, our success in
defending legal proceedings brought against us, trends in the
medical device industry, general economic conditions, and other
risks. For a discussion of these and other risks, uncertainties and
other factors that could affect our results, you should refer to
the disclosure contained in our most recent annual report on Form
10-K filed with the U.S. Securities and Exchange Commission,
including the sections labeled “Risk Factors” and “Cautionary Note
Concerning Forward-Looking Statements,” and in our Forms 10-Q,
Forms 8-K and other filings with the U.S. Securities and Exchange
Commission. These documents are available at www.sec.gov. Moreover,
we operate in an evolving environment. New risk factors and
uncertainties emerge from time to time and it is not possible for
us to predict all risk factors and uncertainties, nor can we assess
the impact of all factors on our business or the extent to which
any factor, or combination of factors, may cause actual results to
differ materially from those contained in any forward-looking
statements. Given these risks and uncertainties, readers are
cautioned not to place undue reliance on any forward-looking
statements. Forward-looking statements contained in this press
release speak only as of the date of this press release. We
undertake no obligation to update any forward-looking statements as
a result of new information, events or circumstances or other
factors arising or coming to our attention after the date
hereof.
Contacts:
Investors:Brian KearnsSenior
Vice President, Business Development and Investor RelationsPhone:
(610) 930-1800Email:
investors@globusmedical.comwww.globusmedical.com
Media:Moran ChavezSenior
Director, Corporate AffairsPhone: (619) 318-7681Email:
media@nuvasive.com
Globus Medical (NYSE:GMED)
과거 데이터 주식 차트
부터 9월(9) 2024 으로 10월(10) 2024
Globus Medical (NYSE:GMED)
과거 데이터 주식 차트
부터 10월(10) 2023 으로 10월(10) 2024